Rite Aid Corporation (RAD) Analysts See $-0.01 EPS

Rite Aid Corporation (NYSE:RAD) LogoInvestors sentiment increased to 1.12 in Q2 2018. Its up 0.09, from 1.03 in 2018Q1. It improved, as 34 investors sold Rite Aid Corporation shares while 65 reduced holdings. 45 funds opened positions while 66 raised stakes. 576.94 million shares or 10.27% more from 523.20 million shares in 2018Q1 were reported.
Massmutual Trust Co Fsb Adv holds 91 shares. Kbc Nv, a Belgium-based fund reported 98,593 shares. Apg Asset Nv holds 14.98M shares or 0.04% of its portfolio. Credit Suisse Ag reported 744,259 shares stake. Brown Advisory Limited Liability Company invested in 20,955 shares or 0.01% of the stock. Ww Asset Mgmt reported 44,969 shares. Rhumbline Advisers invested in 1.10 million shares. Salzhauer Michael stated it has 0.47% in Rite Aid Corporation (NYSE:RAD). Asset Mgmt Of Georgia Ga Adv holds 0.36% or 280,200 shares. Cohen Cap Mgmt Inc holds 0.02% in Rite Aid Corporation (NYSE:RAD) or 45,367 shares. Moreover, Reilly Advsrs Ltd Limited Liability Company has 0% invested in Rite Aid Corporation (NYSE:RAD). D E Shaw And Company holds 143,810 shares or 0% of its portfolio. 9,130 were accumulated by Advisory Services Network Lc. Atria Invs Ltd Limited Liability Company holds 0% of its portfolio in Rite Aid Corporation (NYSE:RAD) for 10,329 shares. Schwab Charles Invest Mngmt Incorporated holds 7.13 million shares.

Analysts expect Rite Aid Corporation (NYSE:RAD) to report $-0.01 EPS on January, 2.After having $-0.01 EPS previously, Rite Aid Corporation’s analysts see 0.00 % EPS growth. The stock decreased 0.96% or $0.01 during the last trading session, reaching $1.03. About 15.21M shares traded or 33.65% up from the average. Rite Aid Corporation (NYSE:RAD) has declined 44.35% since December 7, 2017 and is downtrending. It has underperformed by 59.97% the S&P500.

Rite Aid Corporation (NYSE:RAD) Ratings Coverage

Among 2 analysts covering Rite Aid (NYSE:RAD), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. Rite Aid had 2 analyst reports since August 13, 2018 according to SRatingsIntel. Goldman Sachs maintained Rite Aid Corporation (NYSE:RAD) rating on Thursday, September 6. Goldman Sachs has “Sell” rating and $1 target. The stock of Rite Aid Corporation (NYSE:RAD) earned “Market Perform” rating by Cowen & Co on Monday, August 13.

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company has market cap of $1.09 billion. The firm operates through Retail Pharmacy and Pharmacy Services divisions. It has a 1.54 P/E ratio. The Retail Pharmacy segment sells prescription drugs; and a range of other merchandise, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products.

More notable recent Rite Aid Corporation (NYSE:RAD) news were published by: Seekingalpha.com which released: “The Right Time To Buy Rite Aid – Seeking Alpha” on September 11, 2018, also Fool.com with their article: “Better Buy: Rite Aid vs. Walgreens Boots Alliance – Motley Fool” published on November 28, 2018, Seekingalpha.com published: “Rite Aid Leadership: Epic Fail – Seeking Alpha” on October 15, 2018. More interesting news about Rite Aid Corporation (NYSE:RAD) were released by: 247Wallst.com and their article: “The 6 Most Shorted NYSE Stocks – 24/7 Wall St.” published on November 12, 2018 as well as Businesswire.com‘s news article titled: “Flu Shots Available at Rite Aid Pharmacies During National Influenza Vaccination Week and Beyond – Business Wire” with publication date: December 03, 2018.

Rite Aid Corporation (NYSE:RAD) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.